Clinical trial
High-frequency Sinusoidal Neurostimulation (BioWave) Versus Transcutaneous Electrical Nerve Stimulation (TENS) for the Treatment of Chronic Low Back Pain
NCT05511181 is registered in ClinicalTrials.gov with BioWave Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High-frequency Sinusoidal Neurostimulation (BioWave) Versus Transcutaneous Electrical Nerve Stimulation (TENS) for the Treatment of Chronic Low Back Pain
- Lead sponsor
- BioWave Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 15, 2022
- Completion date
- June 30, 2023
- Enrollment
- 120 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
chronic pain, low back pain, lumbar pain syndrome